Alba Tiley, head of sustainability at Centrient Pharmaceuticals discusses why a sustainable to developing antibiotics is key to combatting antimicrobial resistance (AMR).
With the emergence of CBD-based medicines, Sarath Chandar, chief scientific officer, SPI Pharma guides readers through the bioavailability challenges facing this sector of the industry.
The world’s leading practitioners in genomics are now shaping a community of experts in Manchester. Health writer and Guardian contributor, Rachel Pugh, investigates the opportunities for local patients and international investors alike.
Rich Quelch, global head of marketing at pharmaceutical packaging provider Origin, discusses the rise in medicinal cannabis and what it means for the pharma market.
Automation is to play a key role in transforming regulatory processes in life sciences, but is AI being oversold by business process delivery partners? Alan White, CEO of Arriello, warns that focussed application is essential to delivering results.
